Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity Yahoo Finance Nawigacja wpisu Lilly signs up to $1.3 billion deal with Superluminal Medicines to develop obesity medicines – Yahoo Finance Eli Lilly to hike UK price of Mounjaro weight-loss, diabetes medicines by 170% – Reuters
